Jane Norma Winter

  • 8254 Citations
1983 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis

Al-Mansour, Z., Li, H., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., Smith, S. M., Marcellus, D. C., Barton, K. P., Mills, G. M., LeBlanc, M., Rimsza, L. M., Forman, S. J., Leonard, J. P., Fisher, R. I., Friedberg, J. W. & 1 others, Stiff, P. J., Jul 3 2019, In : Leukemia and Lymphoma. 60, 8, p. 1934-1941 8 p.

Research output: Contribution to journalArticle

Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the Phase III intergroup trial alliance/CALGB 50303

Bartlett, N. L., Wilson, W. H., Jung, S. H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M. Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., Friedberg, J. W., Staudt, L. M., Wagner-Johnston, N. D., Blum, K. A., Abramson, J. S., Reddy, N. M., Winter, J. N., Chang, J. E., Gopal, A. K., Chadburn, A. & 6 others, Mathew, S., Fisher, R. I., Richards, K. L., Schoder, H., Zelenetz, A. D. & Leonard, J. P., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1790-1799 10 p.

Research output: Contribution to journalArticle

26 Scopus citations

Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL

Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodríguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkær, K., Tam, W., You, H., Bhagat, G., Hsi, E. D. & 13 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Han van Krieken, J., Winter, J. N., Westin, J. R., Pham, L. V., Jeffrey Medeiros, L., Rassidakis, G. Z., Li, Y., Freeman, G. J. & Young, K. H., Apr 2019, In : Cancer Immunology Research. 7, 4, p. 644-657 14 p.

Research output: Contribution to journalArticle

11 Scopus citations

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Xu-Monette, Z. Y., Li, J., Xia, Y., Crossley, B., Bremel, R. D., Miao, Y., Xiao, M., Snyder, T., Manyam, G. C., Tan, X., Zhang, H., Visco, C., Tzankov, A., Dybkaer, K., Bhagat, G., Tam, W., You, H., Hsi, E. D., Van Krieken, J. H., Huh, J. & 10 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, J. T., Xu, B., Li, Y., Kirsch, I. & Young, K. H., Oct 22 2019, In : Journal for immunotherapy of cancer. 7, 1, 272.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Li, L., Sun, R., Miao, Y., Tran, T., Adams, L., Roscoe, N., Xu, B., Manyam, G. C., Tan, X., Zhang, H., Xiao, M., Tzankov, A., Visco, C., Dybkaer, K., Bhagat, G., Tam, W., Hsi, E. D., van Krieken, J. H., You, H., Huh, J. & 13 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Zhang, M., Winter, J. N., Medeiros, L. J., Rassidakis, G. Z., Vaupel, C. A., Li, Y., Dakappagari, N., Xu-Monette, Z. Y. & Young, K. H., Jun 1 2019, In : Modern Pathology. 32, 6, p. 741-754 14 p.

Research output: Contribution to journalArticle

5 Scopus citations

Phase I study of the novel enhancer of zeste homolog 2 (EZH2) inhibitor GSK2816126 in patients with advanced hematologic and solid tumors

Yap, T. A., Winter, J. N., Giulino-Roth, L., Longley, J., Lopez, J., Michot, J. M., Leonard, J. P., Ribrag, V., McCabe, M. T., Creasy, C. L., Stern, M., Dumitrescu, T. P., Wang, X., Frey, S., Carver, J., Horner, T., Oh, C., Khaled, A., Dhar, A. & Johnson, P. W. M., Dec 15 2019, In : Clinical Cancer Research. 25, 24, p. 7331-7339 9 p.

Research output: Contribution to journalArticle

3 Scopus citations

Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status

Behdad, A., Boddy, C. S., Fought, A. J., Taxter, T., Falkiewicz, M. K., Ayers, E., Chen, Q. C., Chen, Y. H., Karmali, R., Pro, B., Winter, J. N., Landsburg, D. J., Gordon, L. I. & Kaplan, J. B., Nov 10 2019, In : Leukemia and Lymphoma. 60, 13, p. 3266-3271 6 p.

Research output: Contribution to journalArticle

2018

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

Wang, X., Cao, X., Sun, R., Tang, C., Tzankov, A., Zhang, J., Manyam, G. C., Xiao, M., Miao, Y., Jabbar, K., Tan, X., Pang, Y., Visco, C., Xie, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L. & 16 others, Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Li, S., Miranda, R. N., Medeiros, L. J., Li, Y., Xu-Monette, Z. Y. & Young, K. H., Jun 2018, In : Neoplasia (United States). 20, 6, p. 574-593 20 p.

Research output: Contribution to journalArticle

12 Scopus citations

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

Yao, Z., Deng, L., Xu-Monette, Z. Y., Manyam, G. C., Jain, P., Tzankov, A., Visco, C., Bhagat, G., Wang, J., Dybkaer, K., Tam, W., Hsi, E. D., Van Krieken, J. H., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Winter, J. N., Piris, M. A., Fayad, L., Liu, Y. & 7 others, Song, Y., Orlowski, R. Z., Kantarjian, H., Medeiros, L. J., Li, Y., Cortes, J. & Young, K. H., Feb 1 2018, In : Leukemia. 32, 2, p. 353-363 11 p.

Research output: Contribution to journalArticle

11 Scopus citations

Multicenter Phase II study of sequential brentuximab vedotin and doxorubicin, vinblastine, and dacarbazine chemotherapy for older patients with untreated classical hodgkin lymphoma

Evens, A. M., Advani, R. H., Helenowski, I. B., Jovanovic, B. D., Winter, J. N., Gordon, L. I., Winte, J. N., Gordon, L. I., Smith, S. M., Fanale, M., Bociek, G. R., Klein, A. K. & Hamlin, P. A., Oct 20 2018, In : Journal of Clinical Oncology. 36, 30, p. 3015-3022 8 p.

Research output: Contribution to journalArticle

30 Scopus citations

NCCN guidelines ® insights hodgkin lymphoma, version 1.2018 featured updates to the NCCN guidelines

Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Armand, P., Bello, C. M., Benitez, C. M., Bierman, P. J., Chen, R., Dabaja, B., Dean, R., Forero, A., Gordon, L. I., Hernandez-Ilizaliturri, F. J., Hochberg, E. P., Huang, J., Johnston, P. B., Kaminski, M. S., Kenkre, V. P. & 15 others, Khan, N., Maddocks, K., Maloney, D. G., Metzger, M., Moore, J. O., Morgan, D., Moskowitz, C. H., Mulroney, C., Rabinovitch, R., Seropian, S., Tao, R., Winter, J. N., Yahalom, J., Burns, J. L. & Ogba, N., Mar 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 3, p. 245-254 10 p.

Research output: Contribution to journalArticle

19 Scopus citations
2017

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

Xia, Y., Xu-Monette, Z. Y., Tzankov, A., Li, X., Manyam, G. C., Murty, V., Bhagat, G., Zhang, S., Pasqualucci, L., Visco, C., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Ponzoni, M. & 13 others, Ferreri, A. J. M., Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Westin, J., Fowler, N., Miranda, R. N., Ok, C. Y., Li, Y., Li, J., Medeiros, L. J. & Young, K. H., Mar 1 2017, In : Leukemia. 31, 3, p. 625-636 12 p.

Research output: Contribution to journalArticle

18 Scopus citations
2016

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

Xu-Monette, Z. Y., Li, L., Byrd, J. C., Jabbar, K. J., Manyam, G. C., De Winde, C. M., Van Den Brand, M., Tzankov, A., Visco, C., Wang, J., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Huh, J., Ponzoni, M. & 12 others, Ferreri, A. J. M., Møller, M. B., Parsons, B. M., Winter, J. N., Wang, M., Hagemeister, F. B., Piris, M. A., Van Krieken, J. H., Medeiros, L. J., Li, Y., Van Spriel, A. B. & Young, K. H., Dec 29 2016, In : Blood. 128, 26, p. 3083-3100 18 p.

Research output: Contribution to journalArticle

22 Scopus citations

Clinical and biologic significance of MYC genetic mutations in de novo diffuse large B-cell lymphoma

Xu-Monette, Z. Y., Deng, Q., Manyam, G. C., Tzankov, A., Li, L., Xia, Y., Wang, X. X., Zou, D., Visco, C., Dybkær, K., Li, J., Zhang, L., Liang, H., Montes-Moreno, S., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D. & 14 others, Choi, W. W. L., Van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Parsons, B. M., Møller, M. B., Wang, S. A., Miranda, R. N., Piris, M. A., Winter, J. N., Medeiros, L. J., Li, Y. & Young, K. H., Jul 15 2016, In : Clinical Cancer Research. 22, 14, p. 3593-3605 13 p.

Research output: Contribution to journalArticle

20 Scopus citations

Cutaneous Involvement in a Case of Intravascular T-Cell Lymphoma with a γδ Phenotype

Martinez-Escala, M. E., Guggina, L. M., Cotliar, J., Winter, J. N. & Guitart, J., Feb 1 2016, In : American Journal of Dermatopathology. 38, 2, p. e27-e29

Research output: Contribution to journalArticle

4 Scopus citations

High Body Mass Index in Elderly Patients with DLBCL Treated with Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex

Zhou, Z., Rademaker, A. W., Gordon, L. I., LaCasce, A. S., Crosby-Thompson, A., Vanderplas, A., Abel, G. A., Rodriguez, M. A., Nademanee, A., Kaminski, M. S., Czuczman, M. S., Millenson, M. M., Zelenetz, A. D., Niland, J., Friedberg, J. W. & Winter, J. N., Oct 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 10, p. 1274-1281 8 p.

Research output: Contribution to journalArticle

3 Scopus citations

Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704

Puvvada, S. D., Stiff, P. J., Leblanc, M., Cook, J. R., Couban, S., Leonard, J. P., Kahl, B., Marcellus, D., Shea, T. C., Winter, J. N., Li, H., Rimsza, L. M., Friedberg, J. W. & Smith, S. M., Sep 1 2016, In : British Journal of Haematology. 174, 5, p. 686-691 6 p.

Research output: Contribution to journalArticle

18 Scopus citations

p63 expression confers significantly better survival outcomes in highrisk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function

Xu-Monette, Z. Y., Zhang, S., Li, X., Manyam, G. C., Wang, X. X., Xia, Y., Visco, C., Tzankov, A., Zhang, L., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, H. J., Huh, J. & 9 others, Ponzoni, M., Ferreri, A. J. M., Zhao, X., Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Medeiros, J. L. & Young, K. H., Jan 1 2016, In : Aging. 8, 2, p. 345-365 21 p.

Research output: Contribution to journalArticle

13 Scopus citations

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

Ye, Q., Xu-Monette, Z. Y., Tzankov, A., Deng, L., Wang, X., Manyam, G. C., Visco, C., Montes-Moreno, S., Zhang, L., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M. & 8 others, Ferreri, A. J. M., Parsons, B. M., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, L. J., Hu, V. D. S. & Young, K. H., Jan 1 2016, In : Oncotarget. 7, 3, p. 2401-2416 16 p.

Research output: Contribution to journalArticle

44 Scopus citations

RelA NF-kB subunit activation as a therapeutic target in diffuse large B-cell lymphoma

Zhang, M., Xu-Monette, Z. Y., Li, L., Manyam, G. C., Visco, C., Tzankov, A., Wang, J., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M. & 7 others, Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Medeiros, L. J., Pham, L. V. & Young, K. H., Jan 1 2016, In : Aging. 8, 12, p. 3321-3340 20 p.

Research output: Contribution to journalArticle

9 Scopus citations

Adverse events during hematopoietic stem cell infusion: Analysis of the infusion product

Vidula, N., Villa, M., Helenowski, I. B., Merchant, M., Jovanovic, B. D., Meagher, R., Mehta, J., Singhal, S., Winter, J. N., Frankfurt, O., Altman, J. K., Williams, S. F. & Gordon, L. I., Nov 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 11, p. e157-e162

Research output: Contribution to journalArticle

4 Scopus citations

Age cutoff for epstein-barr virus-positive diffuse large B-cell lymphoma - is it necessary?

Ok, C. Y., Ye, Q., Li, L., Manyam, G. C., Deng, L., Goswami, R. R., Wang, X., Montes-Moreno, S., Visco, C., Tzankov, A., Dybkaer, K., Zhang, L., Abramson, J., Sohani, A. R., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D. & 14 others, Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Zhang, S., Parsons, B. M., Xu, M., Møller, M. B., Winter, J. N., Piris, M. A., Xu-Monette, Z. Y., Medeiros, L. J. & Young, K. H., Jan 1 2015, In : Oncotarget. 6, 16, p. 13935-13946 12 p.

Research output: Contribution to journalArticle

29 Scopus citations

Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression

Jacobsen, E. D., Sharman, J. P., Oki, Y., Advani, R. H., Winter, J. N., Bello, C. M., Spitzer, G., Palanca-Wessels, M. C., Kennedy, D. A., Levine, P., Yang, J. & Bartlett, N. L., Feb 26 2015, In : Blood. 125, 9, p. 1394-1402 9 p.

Research output: Contribution to journalArticle

130 Scopus citations

Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries

Xu-Monette, Z. Y., Tu, M., Jabbar, K. J., Cao, X., Tzankov, A., Visco, C., Cai, Q., Montes-Moreno, S., An, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Ponzoni, M. & 9 others, Ferreri, A. J. M., Zhao, X., Møller, M. B., Farnen, J. P., Winter, J. N., Piris, M. A., Miranda, R. N., Medeiros, L. J. & Young, K. H., Jan 1 2015, In : Oncotarget. 6, 8, p. 5615-5633 19 p.

Research output: Contribution to journalArticle

39 Scopus citations

Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Xu-Monette, Z. Y., Dabaja, B. S., Wang, X., Tu, M., Manyam, G. C., Tzankov, A., Xia, Y., Zhang, L., Sun, R., Visco, C., Dybkaer, K., Yin, L., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H. & 13 others, Huh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Parsons, B. M., Zhao, X., Winter, J. N., Piris, M. A., McDonnell, T. J., Miranda, R. N., Li, Y., Medeiros, L. J. & Young, K. H., Dec 1 2015, In : Modern Pathology. 28, 12, p. 1555-1573 19 p.

Research output: Contribution to journalArticle

32 Scopus citations

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

Chen, J., Xu-Monette, Z. Y., Deng, L., Shen, Q., Manyam, G. C., Martinez-Lopez, A., Zhang, L., Montes-Moreno, S., Visco, C., Tzankov, A., Yin, L., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Han van Krieken, J. & 10 others, Huh, J., Ponzoni, M., Ferreri, A. J. M., Zhao, X., Møller, M. B., Farnen, J. P., Winter, J. N., Piris, M. A., Pham, L. & Young, K. H., Jan 1 2015, In : Oncotarget. 6, 8, p. 5597-5614 18 p.

Research output: Contribution to journalArticle

37 Scopus citations

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Ok, C. Y., Xu-Monette, Z. Y., Li, L., Manyam, G. C., Montes-Moreno, S., Tzankov, A., Visco, C., Dybkær, K., Routbort, M. J., Zhang, L., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Ponzoni, M. & 9 others, Ferreri, A. J. M., Parsons, B. M., Rao, H., Møller, M. B., Winter, J. N., Piris, M. A., Wang, S. A., Medeiros, L. J. & Young, K. H., Sep 3 2015, In : Modern Pathology. 28, 9, p. 1202-1213 12 p.

Research output: Contribution to journalArticle

13 Scopus citations

Hodgkin Lymphoma, version 2.2015

Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Bello, C. M., Benitez, C. M., Bierman, P. J., Blum, K. A., Chen, R., Dabaja, B., Forero, A., Gordon, L. I., Hernandez-Ilizaliturri, F. J., Hochberg, E. P., Huang, J., Johnston, P. B., Khan, N., Maloney, D. G., Mauch, P. M. & 13 others, Metzger, M., Moore, J. O., Morgan, D., Moskowitz, C. H., Mulroney, C., Poppe, M., Rabinovitch, R., Seropian, S., Tsien, C., Winter, J. N., Yahalom, J., Burns, J. L. & Sundar, H., May 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 5, p. 554-586 33 p.

Research output: Contribution to journalArticle

29 Scopus citations
10 Scopus citations

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

Liu, Z., Xu-Monette, Z. Y., Cao, X., Manyam, G. C., Wang, X., Tzankov, A., Xia, Y., Li, X., Visco, C., Sun, R., Zhang, L., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L. & 11 others, Van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Parsons, B. M., Møller, M. B., Piris, M. A., Winter, J. N., O'Malley, D. P., Medeiros, L. J. & Young, K. H., Oct 3 2015, In : Modern Pathology. 28, 10, p. 1297-1314 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

Li, L., Xu-Monette, Z. Y., Ok, C. Y., Tzankov, A., Manyam, G. C., Sun, R., Visco, C., Zhang, M., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M. & 9 others, Ferreri, A. J. M., Møller, M. B., Wang, J., Parsons, B. M., Winter, J. N., Piris, M. A., Pham, L. V., Jeffrey Medeiros, L. & Young, K. H., Jan 1 2015, In : Oncotarget. 6, 27, p. 23157-23180 24 p.

Research output: Contribution to journalArticle

29 Scopus citations

Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation

Zhou, Z., Gao, J., Popovic, R., Wolniak, K., Parimi, V., Winter, J. N., Licht, J. D. & Chen, Y. H., Oct 3 2015, In : Leukemia and Lymphoma. 56, 10, p. 2895-2901 7 p.

Research output: Contribution to journalArticle

18 Scopus citations
2014

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zhou, Z., Sehn, L. H., Rademaker, A. W., Gordon, L. I., LaCasce, A. S., Crosby-Thompson, A., Vanderplas, A., Zelenetz, A. D., Abel, G. A., Rodriguez, M. A., Nademanee, A., Kaminski, M. S., Czuczman, M. S., Millenson, M., Niland, J., Gascoyne, R. D., Connors, J. M., Friedberg, J. W. & Winter, J. N., Feb 6 2014, In : Blood. 123, 6, p. 837-842 6 p.

Research output: Contribution to journalArticle

395 Scopus citations

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

De Vos, S., Forero-Torres, A., Ansell, S. M., Kahl, B., Cheson, B. D., Bartlett, N. L., Furman, R. R., Winter, J. N., Kaplan, H., Timmerman, J., Whiting, N. C., Drachman, J. G. & Advani, R., Jun 12 2014, In : Journal of Hematology and Oncology. 7, 1, 44.

Research output: Contribution to journalArticle

38 Scopus citations

Characterization of tissue findings in bone marrow biopsy specimens with small monoclonal B-cell populations

Nelson, B. P., Abdul-Nabi, A., Goolsby, C., Winter, J. & Peterson, L. A., May 1 2014, In : American journal of clinical pathology. 141, 5, p. 687-696 10 p.

Research output: Contribution to journalArticle

7 Scopus citations

Clinical implications of phosphorylated STAT3 expression in de Novo diffuse large B-cell lymphoma

Ok, C. Y., Chen, J., Xu-Monette, Z. Y., Tzankov, A., Manyam, G. C., Li, L., Visco, C., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Zhao, X., Ponzoni, M. & 8 others, Ferreri, A. J. M., Bertoni, F., Farnen, J. P., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, L. J. & Young, K. H., Oct 1 2014, In : Clinical Cancer Research. 20, 19, p. 5113-5123 11 p.

Research output: Contribution to journalArticle

41 Scopus citations

Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: Multicentre, single-arm, phase 2 study

Wang, M., Popplewell, L. L., Collins, R. H., Winter, J. N., Goy, A., Kaminski, M. S., Bartlett, N. L., Johnston, P. B., Lister, J., Fanning, S. R., Tuscano, J. M., Beck, J. T., Kaya, H., Robeva, A., Fan, J., Klimovsky, J., Cheung, W., Cherfi, A. & O'Connor, O. A., May 2014, In : British Journal of Haematology. 165, 4, p. 510-518 9 p.

Research output: Contribution to journalArticle

29 Scopus citations

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma

Gentzler, R. D., Evens, A. M., Rademaker, A. W., Weitner, B. B., Mittal, B. B., Dillehay, G. L., Petrich, A. M., Altman, J. K., Frankfurt, O., Variakojis, D., Singhal, S., Mehta, J., Williams, S., Kaminer, L., Gordon, L. I. & Winter, J. N., Jun 2014, In : British Journal of Haematology. 165, 6, p. 793-800 8 p.

Research output: Contribution to journalArticle

26 Scopus citations

Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: A multicentre phase II study

Evens, A. M., Smith, M. R., Lossos, I. S., Helenowski, I., Millenson, M., Winter, J. N., Rosen, S. T. & Gordon, L. I., Aug 2014, In : British Journal of Haematology. 166, 4, p. 514-520 7 p.

Research output: Contribution to journalArticle

13 Scopus citations

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program

Ok, C. Y., Xu-Monette, Z. Y., Tzankov, A., O'Malley, D. P., Montes-Moreno, S., Visco, C., Møller, M. B., Dybkær, K., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Han Van Krieken, J., Ponzoni, M., Farnen, J. P., Piris, M. A., Winter, J. N., Medeiros, L. J. & Young, K. H., Jun 15 2014, In : Cancer. 120, 12, p. 1818-1829 12 p.

Research output: Contribution to journalArticle

23 Scopus citations

Prevalence and clinical implications of Epstein-Barr virus infection in de Novo diffuse large B-cell lymphoma in western countries

Ok, C. Y., Li, L., Xu-Monette, Z. Y., Visco, C., Tzankov, A., Manyam, G. C., Montes-Moreno, S., Dybaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Chen, J., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Ai, W., Ponzoni, M. & 9 others, Ferreri, A. J. M., Farnen, J. P., Møller, M. B., Bueso-Ramos, C. E., Miranda, R. N., Winter, J. N., Piris, M. A., Medeiros, L. J. & Young, K. H., May 1 2014, In : Clinical Cancer Research. 20, 9, p. 2338-2349 12 p.

Research output: Contribution to journalArticle

69 Scopus citations

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Tzankov, A., Xu-Monette, Z. Y., Gerhard, M., Visco, C., Dirnhofer, S., Gisin, N., Dybkaer, K., Orazi, A., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Ponzoni, M., Ferreri, A. J. M., Ye, Q., Winter, J. N., Farnen, J. P., Piris, M. A., Møller, M. B. & 4 others, You, M. J., Mcdonnell, T., Medeiros, L. J. & Young, K. H., Jul 2014, In : Modern Pathology. 27, 7, p. 958-971 14 p.

Research output: Contribution to journalArticle

82 Scopus citations
2013

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma

Hay, A. E., Klimm, B., Chen, B. E., Goergen, H., Shepherd, L. E., Fuchs, M., Gospodarowicz, M. K., Borchmann, P., Connors, J. M., Markova, J., Crump, M., Lohri, A., Winter, J. N., Dörken, B., Pearcey, R. G., Diehl, V., Horning, S. J., Eich, H. T., Engert, A. & Meyer, R. M., Dec 1 2013, In : Annals of Oncology. 24, 12, p. 3065-3069 5 p., mdt389.

Research output: Contribution to journalArticle

37 Scopus citations

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas

Evens, A. M., Rosen, S. T., Helenowski, I., Kline, J., Larsen, A., Colvin, J., Winter, J. N., van Besien, K. M., Gordon, L. I. & Smith, S. M., Oct 1 2013, In : British Journal of Haematology. 163, 1, p. 55-61 7 p.

Research output: Contribution to journalArticle

33 Scopus citations

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma

Stiff, P. J., Unger, J. M., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., Miller, T. P., Tubbs, R. R., Marcellus, D., Friedberg, J. W., Barton, K. P., Mills, G. M., LeBlanc, M., Rimsza, L. M., Forman, S. J. & Fisher, R. I., Jan 1 2013, In : New England Journal of Medicine. 369, 18, p. 1681-1690 10 p.

Research output: Contribution to journalArticle

192 Scopus citations

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: A phase i trial of combined induction therapy and bortezomib consolidation

Roy, R., Evens, A. M., Patton, D., Gallot, L., Larson, A., Rademaker, A., Cilley, J., Spies, S., Variakojis, D., Gordon, L. I. & Winter, J. N., Mar 1 2013, In : Leukemia and Lymphoma. 54, 3, p. 497-502 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: A report from the International DLBCL Rituximab-CHOP Consortium Program Study

Hu, S., Xu-Monette, Z. Y., Balasubramanyam, A., Manyam, G. C., Visco, C., Tzankov, A., Liu, W. M., Miranda, R. N., Zhang, L., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Han van Krieken, J., Huang, Q. & 15 others, Huh, J., Ai, W., Ponzoni, M., Ferreri, A. J. M., Zhao, X., Winter, J. N., Zhang, M., Li, L., Møller, M. B., Piris, M. A., Li, Y., Go, R. S., Wu, L., Medeiros, L. J. & Young, K. H., Jan 1 2013, In : Blood. 121, 14, p. 2715-2724 10 p.

Research output: Contribution to journalArticle

142 Scopus citations

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large b-cell lymphoma: Results of an international phase II trial

Armand, P., Nagler, A., Weller, E. A., Devine, S. M., Avigan, D. E., Chen, Y. B., Kaminski, M. S., Holland, H. K., Winter, J. N., Mason, J. R., Fay, J. W., Rizzieri, D. A., Hosing, C. M., Ball, E. D., Uberti, J. P., Lazarus, H. M., Mapara, M. Y., Gregory, S. A., Timmerman, J. M., Andorsky, D. & 4 others, Or, R., Waller, E. K., Rotem-Yehudar, R. & Gordon, L. I., Nov 20 2013, In : Journal of Clinical Oncology. 31, 33, p. 4199-4206 8 p.

Research output: Contribution to journalArticle

338 Scopus citations